Status:
RECRUITING
Statin Combined with Amlodipine Treats Primary Aldosteronism
Lead Sponsor:
Third Military Medical University
Conditions:
Primary Aldosteronism
Statin
Eligibility:
All Genders
18-70 years
Phase:
PHASE4
Brief Summary
The drug treatment for primary aldosteronism (PA) is limited and difficult to improve long-term cardiovascular outcomes. This study plans to enroll patients with primary aldosteronism and randomly div...
Eligibility Criteria
Inclusion
- Clinical diagnosis of primary aldosteronism
Exclusion
- Allergy to drugs in this study
- Pregnancy
- Severe liver and kidney dysfunction
- Mental illness
Key Trial Info
Start Date :
September 10 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 30 2026
Estimated Enrollment :
180 Patients enrolled
Trial Details
Trial ID
NCT06523465
Start Date
September 10 2024
End Date
September 30 2026
Last Update
November 22 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
No. 10 Changjiang River Branch, Yuzhong District，Chongqing, China
Chongqing, Chongqing Municipality, China, 400042